The Market Reports

Index

1 Market Overview
1.1 Product Overview and Scope of Kinase Inhibitors
1.2 Classification of Kinase Inhibitors by Type
1.2.1 Overview: Global Kinase Inhibitors Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Kinase Inhibitors Revenue Market Share by Type in 2021
1.2.3 Non-receptor Tyrosine Kinase Inhibitors
1.2.4 Receptor Tyrosine Kinase Inhibitors
1.2.5 Multikinase Inhibitors
1.2.6 Serine/Threonine Kinase Inhibitors
1.2.7 Protein Kinase C Inhibitors
1.2.8 RHO Kinase Inhibitors
1.2.9 Others
1.3 Global Kinase Inhibitors Market by Application
1.3.1 Overview: Global Kinase Inhibitors Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Inflammatory Diseases
1.3.4 Others
1.4 Global Kinase Inhibitors Market Size & Forecast
1.5 Global Kinase Inhibitors Market Size and Forecast by Region
1.5.1 Global Kinase Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Kinase Inhibitors Market Size by Region, (2017-2022)
1.5.3 North America Kinase Inhibitors Market Size and Prospect (2017-2028)
1.5.4 Europe Kinase Inhibitors Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Kinase Inhibitors Market Size and Prospect (2017-2028)
1.5.6 South America Kinase Inhibitors Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Kinase Inhibitors Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Kinase Inhibitors Market Drivers
1.6.2 Kinase Inhibitors Market Restraints
1.6.3 Kinase Inhibitors Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Kinase Inhibitors Product and Solutions
2.1.4 Merck Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Merck Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Kinase Inhibitors Product and Solutions
2.2.4 Novartis Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Kinase Inhibitors Product and Solutions
2.3.4 Pfizer Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Kinase Inhibitors Product and Solutions
2.4.4 Sanofi Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Kinase Inhibitors Product and Solutions
2.5.4 GlaxoSmithKline Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Biogen Idec
2.6.1 Biogen Idec Details
2.6.2 Biogen Idec Major Business
2.6.3 Biogen Idec Kinase Inhibitors Product and Solutions
2.6.4 Biogen Idec Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Biogen Idec Recent Developments and Future Plans
2.7 Bayer Healthcare Pharmaceuticals
2.7.1 Bayer Healthcare Pharmaceuticals Details
2.7.2 Bayer Healthcare Pharmaceuticals Major Business
2.7.3 Bayer Healthcare Pharmaceuticals Kinase Inhibitors Product and Solutions
2.7.4 Bayer Healthcare Pharmaceuticals Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Bayer Healthcare Pharmaceuticals Recent Developments and Future Plans
2.8 Johnson
2.8.1 Johnson Details
2.8.2 Johnson Major Business
2.8.3 Johnson Kinase Inhibitors Product and Solutions
2.8.4 Johnson Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Johnson Recent Developments and Future Plans
2.9 Tolero Pharmaceutical
2.9.1 Tolero Pharmaceutical Details
2.9.2 Tolero Pharmaceutical Major Business
2.9.3 Tolero Pharmaceutical Kinase Inhibitors Product and Solutions
2.9.4 Tolero Pharmaceutical Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Tolero Pharmaceutical Recent Developments and Future Plans
2.10 Astellas Pharma Inc
2.10.1 Astellas Pharma Inc Details
2.10.2 Astellas Pharma Inc Major Business
2.10.3 Astellas Pharma Inc Kinase Inhibitors Product and Solutions
2.10.4 Astellas Pharma Inc Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Astellas Pharma Inc Recent Developments and Future Plans
2.11 Eli Lilly and Co
2.11.1 Eli Lilly and Co Details
2.11.2 Eli Lilly and Co Major Business
2.11.3 Eli Lilly and Co Kinase Inhibitors Product and Solutions
2.11.4 Eli Lilly and Co Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Eli Lilly and Co Recent Developments and Future Plans
2.12 Incyte Corp
2.12.1 Incyte Corp Details
2.12.2 Incyte Corp Major Business
2.12.3 Incyte Corp Kinase Inhibitors Product and Solutions
2.12.4 Incyte Corp Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Incyte Corp Recent Developments and Future Plans
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Kinase Inhibitors Product and Solutions
2.13.4 AstraZeneca Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 AstraZeneca Recent Developments and Future Plans
2.14 Bristol-Myers Squibb
2.14.1 Bristol-Myers Squibb Details
2.14.2 Bristol-Myers Squibb Major Business
2.14.3 Bristol-Myers Squibb Kinase Inhibitors Product and Solutions
2.14.4 Bristol-Myers Squibb Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.15 Boehringer Ingelheim International GmbH
2.15.1 Boehringer Ingelheim International GmbH Details
2.15.2 Boehringer Ingelheim International GmbH Major Business
2.15.3 Boehringer Ingelheim International GmbH Kinase Inhibitors Product and Solutions
2.15.4 Boehringer Ingelheim International GmbH Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
2.16 F. Hoffmann-La Roche Ltd
2.16.1 F. Hoffmann-La Roche Ltd Details
2.16.2 F. Hoffmann-La Roche Ltd Major Business
2.16.3 F. Hoffmann-La Roche Ltd Kinase Inhibitors Product and Solutions
2.16.4 F. Hoffmann-La Roche Ltd Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.17 Eisai Co., Ltd.
2.17.1 Eisai Co., Ltd. Details
2.17.2 Eisai Co., Ltd. Major Business
2.17.3 Eisai Co., Ltd. Kinase Inhibitors Product and Solutions
2.17.4 Eisai Co., Ltd. Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Eisai Co., Ltd. Recent Developments and Future Plans
2.18 BerGenBio
2.18.1 BerGenBio Details
2.18.2 BerGenBio Major Business
2.18.3 BerGenBio Kinase Inhibitors Product and Solutions
2.18.4 BerGenBio Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 BerGenBio Recent Developments and Future Plans
2.19 Rigel Pharmaceuticals
2.19.1 Rigel Pharmaceuticals Details
2.19.2 Rigel Pharmaceuticals Major Business
2.19.3 Rigel Pharmaceuticals Kinase Inhibitors Product and Solutions
2.19.4 Rigel Pharmaceuticals Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Rigel Pharmaceuticals Recent Developments and Future Plans
2.20 Mirati Therapeutics
2.20.1 Mirati Therapeutics Details
2.20.2 Mirati Therapeutics Major Business
2.20.3 Mirati Therapeutics Kinase Inhibitors Product and Solutions
2.20.4 Mirati Therapeutics Kinase Inhibitors Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Mirati Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Kinase Inhibitors Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Kinase Inhibitors Players Market Share in 2021
3.2.2 Top 10 Kinase Inhibitors Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Kinase Inhibitors Players Head Office, Products and Services Provided
3.4 Kinase Inhibitors Mergers & Acquisitions
3.5 Kinase Inhibitors New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Kinase Inhibitors Revenue and Market Share by Type (2017-2022)
4.2 Global Kinase Inhibitors Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Kinase Inhibitors Revenue Market Share by Application (2017-2022)
5.2 Global Kinase Inhibitors Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Kinase Inhibitors Revenue by Type (2017-2028)
6.2 North America Kinase Inhibitors Revenue by Application (2017-2028)
6.3 North America Kinase Inhibitors Market Size by Country
6.3.1 North America Kinase Inhibitors Revenue by Country (2017-2028)
6.3.2 United States Kinase Inhibitors Market Size and Forecast (2017-2028)
6.3.3 Canada Kinase Inhibitors Market Size and Forecast (2017-2028)
6.3.4 Mexico Kinase Inhibitors Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Kinase Inhibitors Revenue by Type (2017-2028)
7.2 Europe Kinase Inhibitors Revenue by Application (2017-2028)
7.3 Europe Kinase Inhibitors Market Size by Country
7.3.1 Europe Kinase Inhibitors Revenue by Country (2017-2028)
7.3.2 Germany Kinase Inhibitors Market Size and Forecast (2017-2028)
7.3.3 France Kinase Inhibitors Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Kinase Inhibitors Market Size and Forecast (2017-2028)
7.3.5 Russia Kinase Inhibitors Market Size and Forecast (2017-2028)
7.3.6 Italy Kinase Inhibitors Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Kinase Inhibitors Revenue by Type (2017-2028)
8.2 Asia-Pacific Kinase Inhibitors Revenue by Application (2017-2028)
8.3 Asia-Pacific Kinase Inhibitors Market Size by Region
8.3.1 Asia-Pacific Kinase Inhibitors Revenue by Region (2017-2028)
8.3.2 China Kinase Inhibitors Market Size and Forecast (2017-2028)
8.3.3 Japan Kinase Inhibitors Market Size and Forecast (2017-2028)
8.3.4 South Korea Kinase Inhibitors Market Size and Forecast (2017-2028)
8.3.5 India Kinase Inhibitors Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Kinase Inhibitors Market Size and Forecast (2017-2028)
8.3.7 Australia Kinase Inhibitors Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Kinase Inhibitors Revenue by Type (2017-2028)
9.2 South America Kinase Inhibitors Revenue by Application (2017-2028)
9.3 South America Kinase Inhibitors Market Size by Country
9.3.1 South America Kinase Inhibitors Revenue by Country (2017-2028)
9.3.2 Brazil Kinase Inhibitors Market Size and Forecast (2017-2028)
9.3.3 Argentina Kinase Inhibitors Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Kinase Inhibitors Revenue by Type (2017-2028)
10.2 Middle East & Africa Kinase Inhibitors Revenue by Application (2017-2028)
10.3 Middle East & Africa Kinase Inhibitors Market Size by Country
10.3.1 Middle East & Africa Kinase Inhibitors Revenue by Country (2017-2028)
10.3.2 Turkey Kinase Inhibitors Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Kinase Inhibitors Market Size and Forecast (2017-2028)
10.3.4 UAE Kinase Inhibitors Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Kinase Inhibitors Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Kinase Inhibitors Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Kinase Inhibitors Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Kinase Inhibitors Revenue (USD Million) by Region (2017-2022)
Table 5. Global Kinase Inhibitors Revenue Market Share by Region (2023-2028)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Kinase Inhibitors Product and Solutions
Table 9. Merck Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Kinase Inhibitors Product and Solutions
Table 13. Novartis Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Kinase Inhibitors Product and Solutions
Table 17. Pfizer Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Kinase Inhibitors Product and Solutions
Table 21. Sanofi Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Kinase Inhibitors Product and Solutions
Table 25. GlaxoSmithKline Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 27. Biogen Idec Major Business
Table 28. Biogen Idec Kinase Inhibitors Product and Solutions
Table 29. Biogen Idec Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Bayer Healthcare Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Bayer Healthcare Pharmaceuticals Major Business
Table 32. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Product and Solutions
Table 33. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson Major Business
Table 36. Johnson Kinase Inhibitors Product and Solutions
Table 37. Johnson Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Tolero Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 39. Tolero Pharmaceutical Major Business
Table 40. Tolero Pharmaceutical Kinase Inhibitors Product and Solutions
Table 41. Tolero Pharmaceutical Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Astellas Pharma Inc Corporate Information, Head Office, and Major Competitors
Table 43. Astellas Pharma Inc Major Business
Table 44. Astellas Pharma Inc Kinase Inhibitors Product and Solutions
Table 45. Astellas Pharma Inc Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Eli Lilly and Co Corporate Information, Head Office, and Major Competitors
Table 47. Eli Lilly and Co Major Business
Table 48. Eli Lilly and Co Kinase Inhibitors Product and Solutions
Table 49. Eli Lilly and Co Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Incyte Corp Corporate Information, Head Office, and Major Competitors
Table 51. Incyte Corp Major Business
Table 52. Incyte Corp Kinase Inhibitors Product and Solutions
Table 53. Incyte Corp Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 55. AstraZeneca Major Business
Table 56. AstraZeneca Kinase Inhibitors Product and Solutions
Table 57. AstraZeneca Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 59. Bristol-Myers Squibb Major Business
Table 60. Bristol-Myers Squibb Kinase Inhibitors Product and Solutions
Table 61. Bristol-Myers Squibb Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Boehringer Ingelheim International GmbH Corporate Information, Head Office, and Major Competitors
Table 63. Boehringer Ingelheim International GmbH Major Business
Table 64. Boehringer Ingelheim International GmbH Kinase Inhibitors Product and Solutions
Table 65. Boehringer Ingelheim International GmbH Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 67. F. Hoffmann-La Roche Ltd Major Business
Table 68. F. Hoffmann-La Roche Ltd Kinase Inhibitors Product and Solutions
Table 69. F. Hoffmann-La Roche Ltd Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Eisai Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 71. Eisai Co., Ltd. Major Business
Table 72. Eisai Co., Ltd. Kinase Inhibitors Product and Solutions
Table 73. Eisai Co., Ltd. Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. BerGenBio Corporate Information, Head Office, and Major Competitors
Table 75. BerGenBio Major Business
Table 76. BerGenBio Kinase Inhibitors Product and Solutions
Table 77. BerGenBio Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Rigel Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 79. Rigel Pharmaceuticals Major Business
Table 80. Rigel Pharmaceuticals Kinase Inhibitors Product and Solutions
Table 81. Rigel Pharmaceuticals Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Mirati Therapeutics Corporate Information, Head Office, and Major Competitors
Table 83. Mirati Therapeutics Major Business
Table 84. Mirati Therapeutics Kinase Inhibitors Product and Solutions
Table 85. Mirati Therapeutics Kinase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Global Kinase Inhibitors Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 87. Global Kinase Inhibitors Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 88. Breakdown of Kinase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Kinase Inhibitors Players Head Office, Products and Services Provided
Table 90. Kinase Inhibitors Mergers & Acquisitions in the Past Five Years
Table 91. Kinase Inhibitors New Entrants and Expansion Plans
Table 92. Global Kinase Inhibitors Revenue (USD Million) by Type (2017-2022)
Table 93. Global Kinase Inhibitors Revenue Share by Type (2017-2022)
Table 94. Global Kinase Inhibitors Revenue Forecast by Type (2023-2028)
Table 95. Global Kinase Inhibitors Revenue by Application (2017-2022)
Table 96. Global Kinase Inhibitors Revenue Forecast by Application (2023-2028)
Table 97. North America Kinase Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 98. North America Kinase Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 99. North America Kinase Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 100. North America Kinase Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 101. North America Kinase Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 102. North America Kinase Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 103. Europe Kinase Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 104. Europe Kinase Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 105. Europe Kinase Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 106. Europe Kinase Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 107. Europe Kinase Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 108. Europe Kinase Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 109. Asia-Pacific Kinase Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 110. Asia-Pacific Kinase Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 111. Asia-Pacific Kinase Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 112. Asia-Pacific Kinase Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 113. Asia-Pacific Kinase Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 114. Asia-Pacific Kinase Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 115. South America Kinase Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 116. South America Kinase Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 117. South America Kinase Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 118. South America Kinase Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 119. South America Kinase Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 120. South America Kinase Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 121. Middle East & Africa Kinase Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 122. Middle East & Africa Kinase Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 123. Middle East & Africa Kinase Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 124. Middle East & Africa Kinase Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 125. Middle East & Africa Kinase Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 126. Middle East & Africa Kinase Inhibitors Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Kinase Inhibitors Picture
Figure 2. Global Kinase Inhibitors Revenue Market Share by Type in 2021
Figure 3. Non-receptor Tyrosine Kinase Inhibitors
Figure 4. Receptor Tyrosine Kinase Inhibitors
Figure 5. Multikinase Inhibitors
Figure 6. Serine/Threonine Kinase Inhibitors
Figure 7. Protein Kinase C Inhibitors
Figure 8. RHO Kinase Inhibitors
Figure 9. Others
Figure 10. Kinase Inhibitors Revenue Market Share by Application in 2021
Figure 11. Oncology Picture
Figure 12. Inflammatory Diseases Picture
Figure 13. Others Picture
Figure 14. Global Kinase Inhibitors Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Kinase Inhibitors Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Kinase Inhibitors Revenue Market Share by Region (2017-2028)
Figure 17. Global Kinase Inhibitors Revenue Market Share by Region in 2021
Figure 18. North America Kinase Inhibitors Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Kinase Inhibitors Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Kinase Inhibitors Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Kinase Inhibitors Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Kinase Inhibitors Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Kinase Inhibitors Market Drivers
Figure 24. Kinase Inhibitors Market Restraints
Figure 25. Kinase Inhibitors Market Trends
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Sanofi Recent Developments and Future Plans
Figure 30. GlaxoSmithKline Recent Developments and Future Plans
Figure 31. Biogen Idec Recent Developments and Future Plans
Figure 32. Bayer Healthcare Pharmaceuticals Recent Developments and Future Plans
Figure 33. Johnson Recent Developments and Future Plans
Figure 34. Tolero Pharmaceutical Recent Developments and Future Plans
Figure 35. Astellas Pharma Inc Recent Developments and Future Plans
Figure 36. Eli Lilly and Co Recent Developments and Future Plans
Figure 37. Incyte Corp Recent Developments and Future Plans
Figure 38. AstraZeneca Recent Developments and Future Plans
Figure 39. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 40. Boehringer Ingelheim International GmbH Recent Developments and Future Plans
Figure 41. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 42. Eisai Co., Ltd. Recent Developments and Future Plans
Figure 43. BerGenBio Recent Developments and Future Plans
Figure 44. Rigel Pharmaceuticals Recent Developments and Future Plans
Figure 45. Mirati Therapeutics Recent Developments and Future Plans
Figure 46. Global Kinase Inhibitors Revenue Share by Players in 2021
Figure 47. Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 48. Global Top 3 Players Kinase Inhibitors Revenue Market Share in 2021
Figure 49. Global Top 10 Players Kinase Inhibitors Revenue Market Share in 2021
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 51. Global Kinase Inhibitors Revenue Share by Type in 2021
Figure 52. Global Kinase Inhibitors Market Share Forecast by Type (2023-2028)
Figure 53. Global Kinase Inhibitors Revenue Share by Application in 2021
Figure 54. Global Kinase Inhibitors Market Share Forecast by Application (2023-2028)
Figure 55. North America Kinase Inhibitors Sales Market Share by Type (2017-2028)
Figure 56. North America Kinase Inhibitors Sales Market Share by Application (2017-2028)
Figure 57. North America Kinase Inhibitors Revenue Market Share by Country (2017-2028)
Figure 58. United States Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Canada Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Mexico Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Europe Kinase Inhibitors Sales Market Share by Type (2017-2028)
Figure 62. Europe Kinase Inhibitors Sales Market Share by Application (2017-2028)
Figure 63. Europe Kinase Inhibitors Revenue Market Share by Country (2017-2028)
Figure 64. Germany Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. France Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. United Kingdom Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Russia Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Italy Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Asia-Pacific Kinase Inhibitors Sales Market Share by Type (2017-2028)
Figure 70. Asia-Pacific Kinase Inhibitors Sales Market Share by Application (2017-2028)
Figure 71. Asia-Pacific Kinase Inhibitors Revenue Market Share by Region (2017-2028)
Figure 72. China Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Japan Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Korea Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. India Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Southeast Asia Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Australia Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South America Kinase Inhibitors Sales Market Share by Type (2017-2028)
Figure 79. South America Kinase Inhibitors Sales Market Share by Application (2017-2028)
Figure 80. South America Kinase Inhibitors Revenue Market Share by Country (2017-2028)
Figure 81. Brazil Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Argentina Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Middle East and Africa Kinase Inhibitors Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Kinase Inhibitors Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Kinase Inhibitors Revenue Market Share by Country (2017-2028)
Figure 86. Turkey Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Saudi Arabia Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. UAE Kinase Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source